Atlas Trials

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Clinical trial NCT00823992 · COMPLETED

Trial details

NCT number
NCT00823992
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2009-01-01
Primary completion
2010-05-01
Enrollment
305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.